With 2021 right around the corner, you should know emerging startups that will impact the BioTech sector in the coming year. Furthermore, 5 hand-picked, global startups that were founded in 2020 and develop innovative solutions for your sector.

We analyzed 3.060 BioTech startups founded in the last 5 years to identify top startups in the industry. You will discover 5 emerging BioTech startups founded in 2020. And, the 5 promising BioTech startups you should watch in 2021 were hand-picked based on our data-driven startup scouting approach, taking into account factors such as location, founding year, and relevance of technology, among others.

The status Insights Discovery Platform gives you the most exhaustive collection and ensures you continuously discover new startups, scaleups, and technologies.

Top 5 biotech startups you should watch in 2021

Global Startup Heat Map: 5 BioTech Startups to Watch in 2021

The Global Startup Heat Map below highlights 5 BioTech startups, established in 2020, developing technology-driven solutions for the BioTech industry. And, you can explore global hotspots for BioTech startups and even download this graphic to include in your next presentation.

1. Auxilius – Clinical Trial Financial Management

Startups are reliant on clinical research organizations (CROs) to bring a novel drug to the market. Furthermore, CROs have no formal methods to assess the risk to budget. As a result, this leads to a large number of drug trials failing because of a lack of funding.

It leads to millions in sunk costs, as well as the loss of potential drugs. Biotech startups are developing clinical trial financial management solutions that address this gap.

The platform helps biotech companies ensure that outsourced partners meet the contract terms, budgets, and milestones. And, The US-based startup Auxilius develops a data-driven, clinical trial financial management platform. Besides, the solution performs proactive scenario modelling to adjust costs and timelines throughout the clinical trials. By managing financial risk, Auxilius’ platform improves the success of clinical trials.

2. Biomilq – Cultured Milk

One of the biggest problems BioTech is tackling is the unsustainable and unethical scale of industrial production of animal-based foods. And, cultured meat and milk replace animals with cellular agriculture to provide sustainable and scalable food production.

Startups are working on a range of alternatives, largely classified into plant-based and cultured alternatives. BIOMILQ is a US-based biotech startup working on cultured milk. The startup’s patent-pending process uses mammary cells from expectant mothers.

The startup’s solution is a more comprehensive and sustainable breastmilk alternative when compared to infant supplements.

3. Curative

Quickly following the coronavirus outbreak, many diagnosis startups and companies developed COVID-19 testing solutions. Furthermore, the different tests use quantitative PCR or antibody-testing to detect the virus in a few hours or days. Beyond the pandemic, startups are working on a range of diagnostics tests for infectious diseases.

The US-based startup Curative develops a COVID-19 testing solution. Originally founded to develop tests for sepsis, the startup quickly pivoted to respond to the coronavirus pandemic. The test takes only 20 seconds, and the startup delivers results via text and email within 2 days.

4. Kumuda – Small Molecule Drugs

AI enables startups to leverage a large amount of omics and chemical data for data-driven target discovery. Besides, it allows researchers to screen the chemical space efficiently to discover lead molecules with desired properties.

Pharma and biotech startups are investigating small molecule drugs for a large number of conditions, including unmet clinical needs. Kumuda is a US-based startup accelerating the early-stage discovery of small molecule drugs. The inhibitor candidate blocks the human ACE2 receptor, preventing the entry of the SARS-CoV-2 virus. The startup is also targeting neurological disorders and other diseases.

5. Adnexi

Patient advocacy groups (PAGs) ensure patient rights and generate support for certain drugs, particularly for unmet clinical needs and rare and orphan diseases. Moreover, although a relatively recent development, BioTech startups are increasingly turning to disease intelligence to identify opportunities.

Adnexi is a US-based startup that offers a disease intelligence platform for biopharma. The platform discovers patient advocacy groups (PAGs) and key opinion leaders (KOLs). And, the platform keeps track of the treatment ecosystem for a disease to track all organizations developing treatments.